CADE approves Ultrapar pharma divestment with remedies

Lefosse has helped Brazil’s Pague Menos acquire fellow pharmacy chain Extrafarma from local conglomerate Ultrapar for 737 million reais (US$143 million), a deal in which antitrust watchdog CADE has requested the target to sell certain assets.

Unlock unlimited access to all Latin Lawyer content